Overview of the drug. Ibuprofen 100 MG + Para 162.50 MG Syp is a liquid oral formulation of Ibuprofen and Paracetamol. It's a very significant formulation from the general medicine and pediatric product section. The balance in its combination, which is 100 mg of Ibuprofen with 162.50 mg of Paracetamol is one unique professional combination and can be very beneficial to the company manufacturing the oral suspension or syrup formulation. This formulation is usually seen in the product portfolio of many of the PCD pharma franchise companies, third party manufacturers as well as branded medicine manufacturers. The syrup dosage form itself offers an ease in packaging, storage and transit and different channels of medicine. This formulation with appropriate standards and packaging can become one of the strengths of a company's product portfolio.
Details on the Composition. Each 5ml generally contains Ibuprofen 100mg and Paracetamol 162.50mg as the major constituent. Ibuprofen is a popular pharmaceutical ingredient, whereas Paracetamol is probably one of the most popular ones in the general medicine. Both the ingredients give a strong composition profile and an acceptance among the pharma sector. A properly developed liquid should taste good, and have appropriate texture, viscosity, stability and uniformity throughout its shelf life. Pharmaceutical grade excipients, suspending agents, sweeteners, flavors and stabilizers should be included.
Manufacturing. Manufacture of Ibuprofen 100 MG + Para 162.50 MG Syp requires appropriate manufacturing and production standards. Manufacturers should strictly adhere to quality control and hygiene while preparing this formulation using suitable machinery, raw materials and processing. Each stage of the process should be carried out under expert guidance. Quality checks are important, ranging from analysis of the raw materials to inspection of solution or suspension at various stages, pH, viscosity, fill accuracy, finished product checks, seal checks and packaging review. As a liquid formulation, it requires more emphasis on proper processing conditions to yield consistency. GMP helps maintaining the batch-to-batch consistency and value of the product.
Packaging, Labeling and Presentation. The packaging of Ibuprofen 100 MG + Para 162.50 MG Syp has to be proper to keep the product safe from leakages, contamination, air, moisture and damage. Typically it is packed in high quality bottles having appropriate measuring cups, along with attractive cartons and other packaging material. The label must include the brand name, strength of salt, quantity, batch number, manufacturing date, expiration date, MRP, storage instructions and company details. Crisp print, easy-to-read font sizes and eye-catching graphics increase the value and trust of the brand. A quality presentation with good artwork in the bottle label and outer carton greatly supports brand awareness.
Market demand and business relevance. Ibuprofen 100 MG + Para 162.50 MG Syp has huge demand due to the inclusion of the product under the children and general medicine portfolio. This product can be one of the main supporting products in enhancing the syrup or suspension range of products for any pharma company. Wholesalers, retailers and distributors and PCD pharma franchise agents consider this product to add value to their product listing in the pharma sector. Many companies include it in their list for the purpose of having an established product under the oral liquid range. A good balanced portfolio of products will always help support long term business success in the market. A well supported product leads to increased trust among distributors and PCD partners and thus contributes to better business opportunities. It fits both new and growing organizations to expand their presence in children or general medicine sector.
This formulation is a definite product from the list for the PCD pharma franchise companies. Oral liquids are a product category with regular market demand and will always require appropriate marketing support from PCD companies like visual aids, reminder cards, prescription pads, product literature,MR bags, bottle mock-ups etc to expand its reach. Franchise distributors can look forward to this formulation as one of the important parts of their portfolio. A pharma company that offers Ibuprofen 100 MG + Para 162.50 MG Syp with quality standards, professional design, monopolized rights, on time delivery and sufficient promotional support will likely find greater business opportunity in the market. It's a quality-driven product with an established position that makes it favorable for the PCD Pharma franchise business.
Overview of the drug. Ibuprofen 100 MG + Para 162.50 MG Syp is a liquid oral formulation of Ibuprofen and Paracetamol. It's a very significant formulation from the general medicine and pediatric product section. The balance in its combination, which is 100 mg of Ibuprofen with 162.50 mg of Paracetamol is one unique professional combination and can be very beneficial to the company manufacturing the oral suspension or syrup formulation. This formulation is usually seen in the product portfolio of many of the PCD pharma franchise companies, third party manufacturers as well as branded medicine manufacturers. The syrup dosage form itself offers an ease in packaging, storage and transit and different channels of medicine. This formulation with appropriate standards and packaging can become one of the strengths of a company's product portfolio.
Details on the Composition. Each 5ml generally contains Ibuprofen 100mg and Paracetamol 162.50mg as the major constituent. Ibuprofen is a popular pharmaceutical ingredient, whereas Paracetamol is probably one of the most popular ones in the general medicine. Both the ingredients give a strong composition profile and an acceptance among the pharma sector. A properly developed liquid should taste good, and have appropriate texture, viscosity, stability and uniformity throughout its shelf life. Pharmaceutical grade excipients, suspending agents, sweeteners, flavors and stabilizers should be included.
Manufacturing. Manufacture of Ibuprofen 100 MG + Para 162.50 MG Syp requires appropriate manufacturing and production standards. Manufacturers should strictly adhere to quality control and hygiene while preparing this formulation using suitable machinery, raw materials and processing. Each stage of the process should be carried out under expert guidance. Quality checks are important, ranging from analysis of the raw materials to inspection of solution or suspension at various stages, pH, viscosity, fill accuracy, finished product checks, seal checks and packaging review. As a liquid formulation, it requires more emphasis on proper processing conditions to yield consistency. GMP helps maintaining the batch-to-batch consistency and value of the product.
Packaging, Labeling and Presentation. The packaging of Ibuprofen 100 MG + Para 162.50 MG Syp has to be proper to keep the product safe from leakages, contamination, air, moisture and damage. Typically it is packed in high quality bottles having appropriate measuring cups, along with attractive cartons and other packaging material. The label must include the brand name, strength of salt, quantity, batch number, manufacturing date, expiration date, MRP, storage instructions and company details. Crisp print, easy-to-read font sizes and eye-catching graphics increase the value and trust of the brand. A quality presentation with good artwork in the bottle label and outer carton greatly supports brand awareness.
Market demand and business relevance. Ibuprofen 100 MG + Para 162.50 MG Syp has huge demand due to the inclusion of the product under the children and general medicine portfolio. This product can be one of the main supporting products in enhancing the syrup or suspension range of products for any pharma company. Wholesalers, retailers and distributors and PCD pharma franchise agents consider this product to add value to their product listing in the pharma sector. Many companies include it in their list for the purpose of having an established product under the oral liquid range. A good balanced portfolio of products will always help support long term business success in the market. A well supported product leads to increased trust among distributors and PCD partners and thus contributes to better business opportunities. It fits both new and growing organizations to expand their presence in children or general medicine sector.
This formulation is a definite product from the list for the PCD pharma franchise companies. Oral liquids are a product category with regular market demand and will always require appropriate marketing support from PCD companies like visual aids, reminder cards, prescription pads, product literature,MR bags, bottle mock-ups etc to expand its reach. Franchise distributors can look forward to this formulation as one of the important parts of their portfolio. A pharma company that offers Ibuprofen 100 MG + Para 162.50 MG Syp with quality standards, professional design, monopolized rights, on time delivery and sufficient promotional support will likely find greater business opportunity in the market. It's a quality-driven product with an established position that makes it favorable for the PCD Pharma franchise business.
High-quality tablets designed for precision, stability, and effective therapeutic results.
Capsules with superior absorption and high efficacy for better patient outcomes.
Easy-to-consume liquid formulations suitable for both children and adults.
Advanced soft gels for improved bioavailability and enhanced effectiveness.